We are live on ! Find out more
SRTS icon

Sensus Healthcare

41 hedge funds and large institutions have $16.4M invested in Sensus Healthcare in 2021 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,050% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 2

249% more capital invested

Capital invested by funds: $4.71M → $16.4M (+$11.7M)

235% more call options, than puts

Call options by funds: $379K | Put options by funds: $113K

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

105% more funds holding

Funds holding: 2041 (+21)

5.83% more ownership

Funds ownership: 7.88%13.71% (+5.8%)

Holders
41
Holders Change
+21
Holders Change %
+105%
% of All Funds
0.63%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
10
Reduced
4
Closed
2
Calls
$379K
Puts
$113K
Net Calls
+$266K
Net Calls Change
+$220K

SRTS Hedge Fund Activity: Q4 2021 in Review

41 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q4 2021, worth a combined $16.4M — up 249% from $4.71M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new SRTS positions and 2 closed out — a net gain of 21 holders — while 10 added to existing stakes and 4 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $1.1M. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $985K sold.

  • 41 institutional investors held Sensus Healthcare (SRTS) as of Q4 2021, up from 20 in Q3 2021.
  • Funds reported $16.4M of Sensus Healthcare stock for Q4 2021, up 249% quarter-over-quarter.
  • 23 funds opened new Sensus Healthcare positions in Q4 2021 and 2 closed out, a net change of +21 holders.
  • The largest Sensus Healthcare buyer in Q4 2021 was EAM Investors, an estimated $1.1M added.
  • The largest Sensus Healthcare seller in Q4 2021 was Invenomic Capital Management, an estimated $985K sold.

Based on aggregated 13F filings for Q4 2021.